Industry News
AbbVie’s rheumatology tool proves popular
A new web-based educational tool is engaging rheumatologists. [ + ]
Pharma Patent Review releases draft report for comment
The Draft Report of the Pharmaceutical Patent Review is now open for comment. [ + ]
Nanosonics signs UK distributor for Trophon EPR
Toshiba Healthcare will this month start distributing Nanosonics’ (ASX:NAN) Trophon EPR ultrasound probe disinfection cabinets. [ + ]
Making molecular movies
Researchers are one step closer to capturing the dynamics of molecular movement at the atomic level. [ + ]
Mesoblast board gets a Rose
Dr Eric Rose, the cardiovascular surgeon who performed the first successful paediatric heart transplant, has joined Mesoblast’s board of directors. [ + ]
Celebrating art, science and cells
Winning images of a cell biology image competition lit up Times Square in New York in April. [ + ]
Phosphagenics partner scores Indian coup
Phosphagenics’ (ASX:POH) Indian licensee has arranged to sell a diclofenac gel using TPM technology to Novartis India. [ + ]
Quarterly R&D tax credit payments one step closer
The federal government has released the draft legislation, to provide the research and development (R&D) tax incentive through quarterly credits, for public comment. [ + ]
Thermo Fisher Scientific to acquire Life Technologies Corporation
Thermo Fisher Scientific and Life Technologies Corporation have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as of year-end 2012). [ + ]
Rapid test device has global impact
Two engineers have changed the way blood is collected and tested thanks to a world-first, fully integrated rapid test device, designed and developed in Australia. [ + ]
Australia celebrates 60 years of nuclear innovation
Sixty years ago today, Federal Parliament passed the Atomic Energy Act - Australia’s first tentative step along a scientific path that led to the formation of one of our country’s leading public research organisations, which has benefited millions of people around the world. [ + ]
Nanosonics expands reach for Trophon EPR
Nanosonics (ASX:NAN) has ramped up compatibility testing for its ultrasound probe disinfection system, adding 219 products from four vendors to the approved list. [ + ]
UWA licenses genetic drug tech to Sarepta
The University of Western Australia has licensed technology covering a prospective treatment for severe muscle-wasting disease DMD to existing partner Sarepta. [ + ]
UBI picks up Vic govt technology voucher
Universal Biosensors (ASX:UBI) and six other companies have secured grants of up to $250K under the Victorian Government’s Technology Implementation Voucher program. [ + ]
Professional development in therapeutics
The ARCS Congress is coming up in Sydney at the beginning of June. [ + ]
